Department of Neurosurgery, John Hunter Hospital, New Lambton Heights, Newcastle, New South Wales, Australia.
Department of Neurosurgery, John Hunter Hospital, New Lambton Heights, Newcastle, New South Wales, Australia.
World Neurosurg. 2020 Jun;138:e151-e159. doi: 10.1016/j.wneu.2020.02.048. Epub 2020 Feb 17.
The clinical prognostic value of the Spinal Instability Neoplastic Score (SINS), in the context of vertebrectomy for neoplasia, has not yet been established. This retrospective study of 134 patients aims to evaluate the efficacy of the SINS to predict outcomes and survival after vertebrectomy for malignancy.
The patients were classified into 2 groups: indeterminate stability (SINS 7-12) and unstable (SINS 13-18). Outcomes assessed included survival days after procedure, neurological function (modified Frankel grade), operative time, blood loss, complications, construct failure, and length of inpatient stay.
The indeterminate group included 68 patients, whereas the unstable group included 66 patients. No patients were classified as stable (SINS 0-6). The median survival was 225 days (interquartile range, 81-522 days). There was a statistically significant difference (P < 0.001) in survival days after vertebrectomy between the indeterminate group (435 days) and the unstable group (126 days). The majority of patients (119) had a favourable Frankel grade after procedure with no significant difference between SINS groups (P = 0.534). There were no differences in the operative time (234 vs. 210; P = 0.130), inpatient hospital length of stay (10 days vs. 11 days; P = 0.152), complications, or need for intensive care admission (intensive care unit) between the 2 cohorts. There was a statistically significant difference (P = 0.006) for intraoperative blood loss between the indeterminate group (1400 mL) and the unstable group (850 mL).
This study demonstrates a statistically significant increased survival in the indeterminate cohort. These results demonstrate the potential ability of the SINS to act as a clinical prognostic tool with regard to survival time.
脊柱不稳定肿瘤评分(SINS)在肿瘤椎体切除术方面的临床预后价值尚未确定。本研究回顾性分析了 134 例患者,旨在评估 SINS 预测肿瘤椎体切除术后结局和生存的效果。
患者分为 2 组:不确定稳定性(SINS 7-12)和不稳定(SINS 13-18)。评估的结局包括手术后生存天数、神经功能(改良 Frankel 分级)、手术时间、出血量、并发症、结构失败和住院时间。
不确定组包括 68 例,不稳定组包括 66 例。无患者被归类为稳定(SINS 0-6)。中位生存时间为 225 天(四分位距,81-522 天)。在椎体切除术后的生存天数方面,不确定组(435 天)与不稳定组(126 天)之间存在统计学显著差异(P < 0.001)。大多数患者(119 例)术后 Frankel 分级良好,2 组之间无统计学差异(P = 0.534)。手术时间(234 比 210;P = 0.130)、住院时间(10 天比 11 天;P = 0.152)、并发症或需要入住重症监护病房(重症监护病房)无差异2 组之间。在不确定组(1400 mL)和不稳定组(850 mL)之间,术中出血量存在统计学显著差异(P = 0.006)。
本研究表明,不确定组的生存时间有统计学显著增加。这些结果表明,SINS 有可能成为一种具有预测生存时间潜力的临床预后工具。